Xencor (XNCR) Short term Debt (2023 - 2026)
Xencor (XNCR) reported Short term Debt of $26.4 million for Q1 2026, down 49.74% year-over-year from $52.5 million in Q1 2025, and down 38.96% quarter-over-quarter from $43.3 million in Q4 2025.
Xencor (XNCR) Short term Debt (2023 - 2026) Analysis & Trends
Xencor (XNCR) has 4 years of Short term Debt data on file, last reported at $26.4 million in Q1 2026.
- Short term Debt for Q1 2026 came in at $26.4 million, down 49.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.4 million (down 49.74% YoY), and the FY2025 annual result was $43.3 million, down 10.69% from the prior year.
- Short term Debt retreated to $26.4 million in Q1 2026 per XNCR's latest filing, from $43.3 million in the prior quarter.
- Over five years, Short term Debt peaked at $52.5 million in Q1 2025 and troughed at $26.4 million in Q1 2026.
- A 4-year average of $41.2 million and a median of $43.9 million in 2024 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2024 and 2026: Short term Debt jumped 74.83% in 2024, then tumbled 49.74% in 2026.
- A 4-year view of Short term Debt shows it stood at $27.7 million in 2023, then jumped by 74.83% to $48.4 million in 2024, then retreated by 10.69% to $43.3 million in 2025, then plunged by 38.96% to $26.4 million in 2026.
- Business Quant data shows XNCR's Short term Debt at $26.4 million in Q1 2026, $43.3 million in Q4 2025, and $45.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.41 Mn |
| Dec 31, 2025 | 43.27 Mn |
| Sep 30, 2025 | 45.36 Mn |
| Jun 30, 2025 | 50.29 Mn |
| Mar 31, 2025 | 52.54 Mn |
| Dec 31, 2024 | 48.45 Mn |
| Sep 30, 2024 | 44.46 Mn |
| Jun 30, 2024 | 38.93 Mn |
| Mar 31, 2024 | 34.20 Mn |
| Dec 31, 2023 | 27.71 Mn |